Latest Sales Growth News

Hydralyte North America reported a 16% rise in Q1 FY25 net sales and improved gross margins, supported by a strategic capital raise and upcoming product launches targeting brain and gut health.

Inventis Limited reported solid Q3 cash generation and strong technology sales growth, while actively pursuing international expansion and a $2.5 million USD capital raise for its US Hazavoid entity.

Cobalt Blue Holdings progresses its Kwinana Cobalt Refinery towards a Final Investment Decision while expanding into copper and base metals through the Halls Creek Project. The cobalt market faces a structural shift amid DRC export restrictions, supporting a strategic corporate rebrand and leadership changes.

Carbonxt Group advances commissioning of its Kentucky activated carbon plant while securing $2.5 million in fresh capital and reporting strong sales growth and cost savings ahead of FY26.

Saferoads Holdings reports a modest quarterly profit driven by cost cuts and prepares to settle the sale of its Road Safety Rentals business, aiming to clear debt and refocus on product sales growth.

Acrux Limited reports strong momentum from recent topical pharmaceutical launches, driving a significant uptick in profit share income expected in the coming quarter. The company also secured nearly $4 million through a placement and share purchase plan, alongside a $1.73 million R&D-backed loan.

Little Green Pharma reported a robust 40% revenue increase for FY25, driven by strong European sales and the strategic acquisition of Health House. The company also advanced clinical research and secured new therapy funding, positioning itself for continued growth.

Constellation Technologies Limited reports sustained sales growth and positive cash flow in Q3 2025, driven by its Callisto Food Safety & Compliance system and strategic market expansion.

Microba Life Sciences reports robust growth in microbiome diagnostic testing across Australia and the UK, while advancing US market entry plans and transitioning its Therapeutics business to a partnering model.

Stockland’s 3Q25 update highlights steady progress on its Waterloo Renewal Project and solid sales in masterplanned communities, supporting maintained FY25 earnings guidance.

PainChek Limited reports strong progress toward FDA De Novo clearance for US market entry, launches its Infant App in Australia, and achieves robust global licence growth with a 30% year-on-year revenue increase.

Coles Group Limited reported a solid 3.4% increase in total group sales revenue for the third quarter of FY25, driven by strong supermarket growth and a significant eCommerce uplift. Operational efficiencies and strategic initiatives helped the retailer navigate challenging weather conditions and maintain momentum.